Telemedicine During COVID-19 for Outpatient Sports and Musculoskeletal Medicine Physicians

Telemedicine During COVID-19 for Outpatient Sports and Musculoskeletal Medicine Physicians
复制标题

DOI:
10.1002/pmrj.12422
复制
发表时间:
2020-07-10
期刊:
影响因子:
2.1
通讯作者:
Borg-Stein, Joanne
Borg-Stein, Joanne
中科院分区:
医学4区
文献类型:
--
作者:
Tenforde, Adam S.;Iaccarino, Mary A.;Borg-Stein, Joanne

文献摘要

被引文献

相似文献

由于SARS-CoV-2的全球大流行,导致了远程医疗的扩展。没有很好地描述患者和医生快速使用的质量和障碍的措施。目的描述大流行期间远程医疗快速采用阶段的质量改进举措的结果。设计患者和医生对同步视听远程医疗访问的满意度在早期采用阶段(2020年4月6日至2020年4月17日)在学术物理医学和康复(PM&R)部门的运动医学部门内进行了测量。患者被邀请在远程医疗访问结束时完成在线调查,参与质量改进计划。医生完成了一项单独的调查。主要结果测量患者测量包括就诊类型、就诊持续时间、质量和满意度。医生报告了进行远程医疗的经验。结果调查完成了119例(293远程医疗遇到,响应率40.6%)和14名物理学家。远程医疗主要用于随访(n = 74,70.6%),最常见的持续时间为15至29分钟。患者将其远程医疗访问评为“优秀”或“非常好”,包括解决问题,沟通,制定治疗计划,便利性和满意度。完成未来远程医疗访问的价值为84.9%。大多数报告估计节省的旅行时间超过30分钟。未入住率为2.7%。大多数医生(57.1%)以前没有远程医疗访问的经验,大多数人在完成1至4次会议后(71%)进行这些访问。几乎所有的医生(92.9%)将他们的远程医疗经验评为非常好或优秀。所查明的远程医疗的主要障碍是技术问题。所有医生都报告说,如果继续报销,他们计划进行远程医疗访问。结论总之,在COVID-19大流行期间,远程医疗的快速扩张受到了大多数患者和医生的欢迎。这表明远程医疗在其他门诊运动医学实践中快速扩展的可行性。
Introduction The global pandemic due to SARS-CoV-2 has resulted in an expansion of telemedicine. Measures of quality and barriers for rapid use by patients and physicians are not well described. Objective To describe results from a quality improvement initiative during a rapid adoptive phase of telemedicine during the pandemic. Design Patient and physician satisfaction with synchronous audiovisual telemedicine visits was measured during the early adoptive phase (6 April 2020-17 April 2020) within the division of sports medicine in an academic Physical Medicine and Rehabilitation (PM&R) department. Patients were invited to participate in a quality improvement initiative by completing an online survey at the end of a telemedicine visit. Physicians completed a separate survey. Primary Outcome Measures Patient measures included visit type, duration of encounter, quality, and satisfaction. Physicians reported on experiences performed telemedicine. Results Surveys were completed by 119 patients (293 telemedicine encounters, response rate 40.6%) and 14 physiatrists. Telemedicine was utilized primarily for follow-up visits (n = 74, 70.6%), and the most common duration was 15 to 29 minutes. Patients rated their telemedicine visit as "excellent" or "very good" across measures (91.6%-95.0%) including addressing concerns, communication, developing a treatment plan, convenience, and satisfaction. Value of completing a future telemedicine visit was measured at 84.9%. Most reported estimated travel time saved was in excess of 30 minutes. Rate of no-show was 2.7%. Most physicians (57.1%) had no prior experience with telemedicine visits, and most were comfortable performing these visits after completing 1 to 4 sessions (71%). Nearly all physicians (92.9%) rated their telemedicine experience as very good or excellent. The key barrier identified for telemedicine was technical issues. All physicians reported plans to perform telemedicine visits if reimbursement continues. Conclusions In summary, rapid expansion of telemedicine during the COVID-19 pandemic was well-received by a majority of patients and physicians. This suggests feasibility in rapid expansion of telemedicine for other outpatient sports medicine practices.